Are DMARDs effective for rheumatologic diseases besides rheumatoid arthritis?

MOspace/Manakin Repository

Breadcrumbs Navigation

Are DMARDs effective for rheumatologic diseases besides rheumatoid arthritis?

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/3596

[-] show simple item record

dc.contributor.author Goodemote, Patricia
dc.contributor.author Jamieson, Barbara
dc.date.accessioned 2009-11-13T19:47:25Z
dc.date.available 2009-11-13T19:47:25Z
dc.date.issued 2007-11 en
dc.identifier.citation Journal of Family Practice, 56(11) 2007: 933+. en
dc.identifier.uri http://hdl.handle.net/10355/3596
dc.description.abstract It's unclear whether disease-modifying antirheumatic agents (DMARDs) as first-line therapy in nonrheumatoid rheumatologic diseases are effective because the question has not been studied. As second-line therapy, the use of some DMARDs appears to be beneficial for patients with psoriatic arthritis (strength of recommendation [SOR: A, based on systematic reviews of good- quality randomized controlled trials) and ankylosing spondylitis (SOR: B, based on systematic reviews of moderate quality trials). Data on the safety and efficacy of DMARDs as second-line therapy for other arthritic conditions is limited (SOR: C, based on small prospective cohort trials). en
dc.language.iso en_US en
dc.publisher Family Physicians Inquiries Network en
dc.relation.ispartof Clinical Inquiries, 2007 (MU) en
dc.subject ankylosing spondylitis en
dc.subject.lcsh Antirheumatic agents en
dc.subject.lcsh Psoriatic arthritis -- Treatment en
dc.subject.lcsh Rheumatism -- Treatment en
dc.title Are DMARDs effective for rheumatologic diseases besides rheumatoid arthritis? en
dc.type Article en
dc.relation.ispartofcommunity University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network


This item appears in the following Collection(s)

[-] show simple item record